Johnson & Johnson (NYSE: JNJ) must pay $15 million to a Connecticut man who alleges that he developed mesothelioma, a […]
Johnson & Johnson Ordered to Pay $15 Million in Talc Powder Cancer Case Read More »
Johnson & Johnson (NYSE: JNJ) raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology
Johnson & Johnson (NYSE: JNJ) Posts Better-than-Expected Q3 Results, Raises 2024 Outlook Read More »
NEW YORK – A Johnson & Johnson (NYSE: JNJ) subsidiary can pursue its third attempt to resolve tens of thousands
J&J Talc Bankruptcy Stays in Texas Despite ‘Forum-Shopping’ Opposition Read More »
On Tuesday, Johnson & Johnson (NYSE: JNJ) said it will invest more than $2 billion to build a new manufacturing
A Johnson & Johnson (NYSE: JNJ) subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant
A state judge in Oregon has overturned a jury’s $260 million verdict against Johnson & Johnson (NYSE: JNJ) in a
NEW YORK – On Friday, Johnson & Johnson (NYSE: JNJ) said it is negotiating with plaintiffs’ lawyers who have opposed
On Tuesday, the U.S. Food and Drug Administration approved Johnson & Johnson’s (NYSE: JNJ) chemotherapy-free combination treatment for a type
US FDA Approves Johnson & Johnson’s Combination Therapy for a Type of Lung Cancer Read More »
NEW YORK – Johnson & Johnson (NYSE: JNJ) is preparing to unveil widespread support in the coming days for a
Copyright © 2024 abbonews.com
